Obstructive vascular disease is an important health problem in the industrialized world. Through a series of molecular genetic studies, we demonstrated that loss-of-function mutations in one elastin allele cause an inherited obstructive arterial disease, supravalvular aortic stenosis (SVAS). To define the mechanism of elastin's effect, we generated mice hemizygous for the elastin gene ( ELN ϩ / Ϫ ). Although ELN mRNA and protein were reduced by 50% in ELN ϩ / Ϫ mice, arterial compliance at physiologic pressures was nearly normal. This discrepancy was explained by a paradoxical increase of 35% in the number of elastic lamellae and smooth muscle in ELN ϩ / Ϫ arteries. Examination of humans with ELN hemizygosity revealed a 2.5-fold increase in elastic lamellae and smooth muscle. 
Introduction
Obstructive vascular disease is the predominant cause of mortality and morbidity in developed nations (1) . Extensive research has implicated key pathogenic roles for lipids and growth factors, but it is likely that other factors participate in the pathogenesis of these disorders. In a series of molecular genetic experiments, we demonstrated that a human obstructive vascular disorder, supravalvular aortic stenosis (SVAS), 1 is associated with hemizygosity of the elastin gene ( ELN ) (2) (3) (4) (5) (6) . Mutations in genes encoding other structural proteins, including collagen and fibrillin, have also been associated with vascular disease, but these genetic abnormalities cause dissection and degeneration, not obstruction (7, 8) . The pathogenic mechanisms underlying ELN mutations are not understood.
Elastin is the dominant arterial extracellular matrix protein, comprising 50% of the dry weight of the aorta (9) . Encoded by a single gene on human chromosome 7q11.23, elastin expression is largely confined to the third trimester of fetal development and early postnatal years. Elastin is synthesized by smooth muscle, secreted as a soluble monomer, tropoelastin, and organized into insoluble polymers that form concentric rings of elastic lamellae around the arterial lumen. Each elastic lamella alternates with a ring of smooth muscle, forming a lamellar unit. Elastic lamella provides the resilience that arteries need to absorb hemodynamic stress of cardiac systole and to release this energy in the form of sustained blood pressure during diastole. The number of lamellar units is thought to be species specific, fixed, and genetically predetermined (10, 11) .
Previously, human pathologic studies of SVAS described medial necrosis, fibrosis, and disorganization, a common endstage pathology of many vascular diseases (12, 13) . Identifying the mechanism of disease through these studies was hampered by the inability to separate cause and effect. To define the pathogenic mechanism underlying SVAS, we characterized mice hemizygous for ELN . This work demonstrates that the number of lamellar units is neither fixed nor species specific, but is modulated by the level of ELN expression during development. We show that humans are extremely sensitive to reduced ELN expression, developing profound thickening of the arterial wall.
Methods

Northern analysis. Poly(A)
ϩ RNA was extracted from the visceral organs of the thorax from mice at birth using a Micro-Fast Tract Kit (Invitrogen, Carlsbad, CA). RNA was electrophoresed on a 1.0% denaturing agarose gel, transferred to Hybond filter (Amersham, Arlington Heights, IL), and hybridized with a 32 P-labeled 0.85-kb fragment of mouse ELN cDNA. Filters were rehybridized with a 1.5-kb fragment of human cardiac actin cDNA. Intensity of bands was measured by PhosphorImager analysis. ELN expression in ELN ϩ / ϩ and ELN ϩ / Ϫ mice was standardized to cardiac actin expression and compared.
Electron microscopy. Ascending thoracic aortae were dissected from mouse pups at birth after cardiac perfusion with 3% glutaraldehyde. Aortic segments were sequentially stained with osmium tetroxide, tannic acid, and uranyl acetate, then dehydrated and embedded in Epon. Thin sections (60-nm) were counterstained with uranyl acetate and lead citrate and examined on a Jeol 1200 electron microscope (14) .
Histological examination. Mice were fixed overnight in either 4% paraformaldehyde or methyl Carnoys at 4 Њ C and embedded in paraffin. Sections were stained with hematoxylin and eosin and Hart stain for elastin. Individuals blinded to the genotype counted lamellar units on two separate occasions. The statistical significance was calculated by comparison of the means using t test analysis.
Vascular extensibility. Arteries studied were cannulated and mounted on the pressure myograph (15) . The vessel was transilluminated under an inverted microscope connected to a CCD camera, allowing the continuous recording of the outer diameter of the vessel. In the ascending aorta, intravascular pressure was increased from 75 to 175 mmHg by steps of 25 mmHg (0-50 mmHg by steps of 10 mmHg for the left pulmonary artery), and the arterial diameter was recorded. Extensibility was calculated using the following formula with 125 mmHg as an example: extensibility ϭ [( diameter at 150 mmHg Ϫ diameter at 100 mmHg )/( diameter at 100 mmHg )] ϫ 100 (16) . Diameter statistical analysis was assessed by a four-way ANOVA followed by least significance difference test for post-ANOVA paired comparisons. Extensibility statistical analysis was assessed by the nonparametric Mann-Whitney U test. P values below 0.05 were considered statistically significant.
Results
To define the role of ELN hemizygosity in arterial disease, we generated mice hemizygous ( ELN ϩ / Ϫ ) for an ELN null mutation using homologous recombination in embryonic stem cells (17) . Three independent recombinant cell lines containing a 4.0-kb deletion of the promoter and exon 1 of ELN were used to generate chimeras. Chimeras were mated to generate ELN ϩ / Ϫ mice. ELN ϩ / Ϫ mice were identical to ELN ϩ / ϩ mice in gross appearance, behavior, and life expectancy. Northern analysis of ELN ϩ / Ϫ mice revealed a 47% decrease in ELN mRNA when compared with ELN ϩ / ϩ mice at birth ( Fig. 1, a and b ) . To determine if the structure of elastic lamellae in ELN ϩ / Ϫ mice was affected by reduced ELN expression, we examined aortic cross-sections by electron microscopy. Elastic lamellae in ELN ϩ / Ϫ aortae (Fig. 1, d and f ) were ‫ف‬ 50% thinner than those in ELN ϩ / ϩ aortae (Fig. 1, c and e ). These data indicate that elastic lamellae in ELN ϩ / Ϫ mice are structurally abnormal.
To determine the physiologic consequences of structural changes observed in ELN ϩ / Ϫ mice, we measured aortic diameter and extensibility at varying intraluminal pressures. Despite differences in ELN mRNA expression and protein deposition, at a physiologic pressure of 100 mmHg ELN ϩ / ϩ and ELN ϩ / Ϫ aortae had similar extensibilities (23.6 Ϯ 0.9 vs. 22.5 Ϯ 0.7%) (Fig. 2) (18) . At 125 mmHg and above, however, the pressure-diameter curves diverged with a marked reduction in extensibility of ELN ϩ / Ϫ aortae (at 125 mmHg, 18.8 Ϯ 1.5% for ELN ϩ /ϩ aortae vs. 11.2Ϯ4% for ELN ϩ/Ϫ aortae, P Ͻ 0.05). The extensibility of ELN ϩ/Ϫ pulmonary arteries was similar to controls within a broad pressure range (0-50 mmHg) surrounding normal physiologic pressure (mean pressure ϭ 10 mmHg). These data indicate that ELN ϩ/Ϫ mice maintain extensibility at physiologic pressures.
To understand the structural determinants enabling ELN ϩ/Ϫ aortae to maintain normal extensibility at physiologic pressure despite a 50% decrease in elastin, we examined the arterial structure. We discovered that aortae dissected from ELN ϩ/Ϫ mice (5-14 mo) had additional lamellar units. Consistent with previous work, we found that ELN ϩ/ϩ aortae had 5.4Ϯ0.5 (descending) and 8.4Ϯ0.5 (ascending) layers of elastic lamellae (Table I and Fig. 3) (10, 19) . By contrast, crosssections of ELN ϩ/Ϫ mice revealed an increase in the number of elastic lamellae to 7.3Ϯ0.6 (descending) and 10.5Ϯ0.5 (ascending) layers, respectively (P Ͻ 0.005). This represented an increase of 35% and 25% for the descending and ascending aortae of ELN ϩ/Ϫ mice, respectively. Similar changes were observed in the pulmonary artery with an average of 7.5Ϯ0.7 lamellar units in ELN ϩ/Ϫ mice vs. 6.1Ϯ0.2 in the ELN ϩ/ϩ mice (P Ͻ 0.005). These changes were also apparent at birth. Our data demonstrate that ELN ϩ/Ϫ mice develop additional rings of elastic lamellae and smooth muscle. Thus, the number of lamellar units in an arterial wall is not fixed or species specific.
To determine if developmental changes observed in the aortae of ELN ϩ/Ϫ mice were also present in humans, we examined aortic segments from individuals with SVAS (n ϭ 2 for affected, n ϭ 3 for controls; Fig. 4 and data not shown). Previous studies focused only on arterial sections affected by discrete stenosis and showed subendothelial accumulation of cells, hypertrophy of smooth muscle, disruption of elastic fibers, and fibrosis (12, 13) . We studied regions of the aorta that were free of discrete stenosis. The number of lamellar units in controls was consistent with previous reports (10, 20) . By contrast, the aortic wall of individuals with SVAS was thicker and contained 2.5-fold more lamellar units (152Ϯ27.6 vs. 62Ϯ8.7; P Ͻ 0.025). These data indicate that humans, like mice, respond to reduced elastin content during development by increasing the number of lamellar units.
Discussion
It was thought previously that the number of lamellar units in a developing arterial wall is fixed and species specific (9, 10). Our work demonstrates that this concept is incorrect. We found that ELN ϩ/Ϫ mice develop arteries with a 25-35% increase in the number of lamellar units. Examination of arterial specimens obtained from individuals with SVAS, a human disorder caused by ELN hemizygosity, revealed a 2.5-fold increase in the number of elastic lamellae. Thus, the number of lamellar units in an arterial wall is not fixed or species specific and is modulated by ELN expression.
Elastin's effect on arterial lamellar development likely involves smooth muscle cells sensing increased wall stress. The reduced ELN mRNA and thinning of each elastic lamella observed in ELN ϩ/Ϫ mice would cause reduced extensibility in each lamella. These changes would lead to increased arterial wall stress, which is determined by arterial pressure and diameter and inversely proportional to the number of lamellar units and the tensile strength of each unit (21) . However, the extensibility and diameter of ELN ϩ/Ϫ arteries were normal at physiologic pressures. Thus, mice with abnormal elastic fibers maintain arterial extensibility by increasing the number of lamellar units during development. Our model is further supported by anatomic and physiologic studies showing that the relationship between wall stress and the number of lamellar units in an artery is remarkably constant across species despite enormous variation in arterial diameter and stress (10) . In addition, we observed no increase in the number of lamellar units when ELN ϩ/Ϫ aortae were cultured in the absence of hemodynamic stress (17 and data not shown). Thus, the physiologic force of wall stress is a key determinant of arterial development. Our work defines a novel pathology in a human obstructive arterial disease, SVAS. Because of arterial pathology in ELN ϩ/Ϫ mice, we examined aortic sections from individuals with SVAS and found a compensatory increase in arterial lamellar units. As human arteries are larger and wall stress is greater (110,000 dynes/cm in humans vs. 7,800 dynes/cm in mice) the increase in humans is profound (2.5-fold increase in humans). The increase in the smooth muscle cells needed to form additional layers likely outstrips blood supply, leading to medial necrosis and fibrosis. These changes in the medial wall would stimulate recurrent injury and repair resulting in the focal stenosis observed in SVAS (12, 13) .
Our data indicate that the number of lamellar units can only be modulated by wall stress early in development. During gestation when pulmonary vascular pressures are similar to systemic pressures, pulmonary arteries respond to ELN hemizygosity by increasing the number of lamellar units. Despite a sharp decrease in hemodynamic stress with onset of respiration at birth, the number of lamellar units in the pulmonary artery does not change. Later in life, lamellar structure is fixed and medial hypertrophy is the primary arterial response to increased hemodynamic stress (22) . This concept is further supported by the failure to observe increased lamellar units in other disorders associated with increased arterial wall stress or decreased elasticity like hypertension, aortic aneurysms, or Marfan's syndrome.
Other factors may also contribute to the risk of obstructive arterial disease by reducing ELN expression during development. Hypervitaminosis D, for example, reduces ELN expression in in vitro and in vivo systems (23, 24) . Animal models exposed to hypervitaminosis D gave birth to offspring that developed SVAS (25, 26) . These data support our model of reduced gestational ELN expression resulting in abnormal vascular development and obstructive vascular disease. Future studies need to define the impact of genetic and environmental modulators of ELN expression on the risk of obstructive vascular disease. 
